Huiping Y. Li

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 181 publications

Neoadjuvant Anbenitamab and HB1801 in ERBB2-Positive Breast Cancer: A Phase 3 Randomized Clinical Trial.

Neoadjuvant Anbenitamab and HB1801 in ERBB2-Positive Breast Cancer: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology

Published: September 03, 2026

Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer: Real-World Outcomes and Treatment Transition Patterns in a Chinese Cohort.

Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer: Real-World Outcomes and Treatment Transition Patterns in a Chinese Cohort.

Journal: Current oncology (Toronto, Ont.)

Published: July 07, 2026

Fovinaciclib for First-Line Therapy of Advanced Breast Cancer: A Randomized Clinical Trial.

Fovinaciclib for First-Line Therapy of Advanced Breast Cancer: A Randomized Clinical Trial.

Journal: JAMA oncology

Published: June 01, 2026

Bireociclib Plus Fulvestrant in Advanced Breast Cancer After Endocrine Progression: The BRIGHT-2 Phase 3 Randomized Clinical Trial.

Bireociclib Plus Fulvestrant in Advanced Breast Cancer After Endocrine Progression: The BRIGHT-2 Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology

Published: March 19, 2026

Abemaciclib in HR+, HER2- Breast Cancer: A Narrative Review of the Clinical Evidence.

Abemaciclib in HR+, HER2- Breast Cancer: A Narrative Review of the Clinical Evidence.

Journal: Oncology and therapy

Published: March 19, 2026

Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial.

Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial.

Journal: BMJ (Clinical research ed.)

Published: March 16, 2026

Clinicopathological discordance and survival outcomes in 154 breast cancer patients with pulmonary metastasis in a real-world setting.

Clinicopathological discordance and survival outcomes in 154 breast cancer patients with pulmonary metastasis in a real-world setting.

Journal: Discover oncology

Published: February 16, 2026

Analysis on epidemiological characteristics of newly diagnosed occupational pneumoconiosis in Beijing from 2005 to 2021

Analysis on epidemiological characteristics of newly diagnosed occupational pneumoconiosis in Beijing from 2005 to 2021

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: February 01, 2026

Navigating first- and second-line treatment options in hormone receptor-positive HER2-negative advanced breast cancer.

Navigating first- and second-line treatment options in hormone receptor-positive HER2-negative advanced breast cancer.

Journal: The oncologist

Published: January 22, 2026

Navigating first- and second-line treatment options in HR+HER2-negative advanced breast cancer.

Navigating first- and second-line treatment options in HR+HER2-negative advanced breast cancer.

Journal: The oncologist

Published: January 22, 2026

Real-world effectiveness of mecapegfilgrastim for prophylaxis in patients with breast cancer receiving 2-weekly and 3-weekly chemotherapy in China.

Real-world effectiveness of mecapegfilgrastim for prophylaxis in patients with breast cancer receiving 2-weekly and 3-weekly chemotherapy in China.

Journal: BMC cancer

Published: January 13, 2026

In reply to the comment on "Mixed reality-assisted orthognathic surgery with pre-bent titanium plates".

In reply to the comment on "Mixed reality-assisted orthognathic surgery with pre-bent titanium plates".

Journal: International journal of oral and maxillofacial surgery

Published: December 19, 2025

Showing 1-12 of 181

Last Updated: 09/26/2026